Page 46 - _NIPER-G Annual Report 2019-201
P. 46

Facilities available in the Department

                     In-vitro drug screening (cell free and cell based) facility.

                     In-vivo  pharmacological  screening  facility  for  the  areas  of  Institute  identified  thrust
                       areas
                     Central Animal house facility according to CPCSEA norms for in vivo pharmacological
                       screening including nude mice facility.
                     In vitro and in vivo imaging facilities.

                     Natural product Extraction and isolation facility

                     Molecular  pharmacology  lab  to  study  molecular  mechanism  of  the  therapeutic
                       compounds (Flow cytometry, Multimode reader, RT PCR, Western blotting setup, fully
                       automated hematology analyzer etc.,)





                                                  Faculty Members


















                        Dr. VGM Naidu                                Dr. Bidya Dhar Sahu                            Dr.Pavan K.Samudrala
                          Associate Professor                                      Assistant Professor                                        Assistant Professor
                          Email:                                                          Email:                                                                  Email:
                vgmnaidu@niperguwahati.ac.in                    bidya.sahu@niperguwahati.ac.in                      pavankumar@niperguwahati.ac.in
               Research Areas:                           Research Areas:                           Research Areas:

               -Cancer and its complications             -Cardio-Renal Pharmacology               -Neuropathic pain
               -Inflammatory disorders                       -Inflammation                                       -Parkinson’s disease
               -Respiratory disorders like                   -Diabetes and its complications.
                 Asthma, COPD and lung fibrosis.















                 NIPER-G                                                                          43
   41   42   43   44   45   46   47   48   49   50   51